Active, not recruitingPhase 2NCT04116411
A Clinical Trial Evaluating the Efficacy of Valganciclovir in Glioblastoma Patients
Studying Giant cell glioblastoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Cecilia Soderberg-Naucler
- Principal Investigator
- Giuseppe Stragliotto, MD, PhDKarolinska University Hospital
- Intervention
- Valganciclovir Tablets(drug)
- Enrollment
- 220 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2019 – 2027
Study locations (3)
- Oslo University Hospital, Oslo, Norway
- Stavanger University Hospital, Stavanger, Norway
- SE01 Karolinska University Hospital, Solna, Stockholm County, Sweden
Collaborators
Karolinska University Hospital · Karolinska Institutet
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04116411 on ClinicalTrials.govOther trials for Giant cell glioblastoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT06176066PH Sensitive MRI Based Resections of GlioblastomaUniversity of California, Los Angeles
- RECRUITINGNCT05864976Neurosurgical Neuronavigation Using Resting State MRI and Machine LearningWashington University School of Medicine
- ACTIVE NOT RECRUITINGPHASE2, PHASE3NCT05685004Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM)TVAX Biomedical
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT04922723Radiation/Temozolomide and Immunotherapy With Daratumumab to Improve Antitumor Efficacy in GlioblastomaWest Virginia University
- RECRUITINGPHASE1NCT05083754Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With GlioblastomaSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- ACTIVE NOT RECRUITINGPHASE1NCT04968366Safety & Efficacy of DC Vaccine and TMZ for the Treatment of Newly-diagnosed Glioblastoma After SurgeryBeijing Tiantan Hospital
- ACTIVE NOT RECRUITINGPHASE2NCT04574856Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in Patients With Newly Diagnosed GlioblastomaUniversity of Michigan Rogel Cancer Center
- RECRUITINGPHASE1, PHASE2NCT03672721IA Carboplatin + Radiotherapy in Relapsing GBMUniversité de Sherbrooke